A Semi-Physiologically Based Pharmacokinetic Model Describing the Altered Metabolism of Midazolam Due to Inflammation in Mice.

Saved in:
Bibliographic Details
Title: A Semi-Physiologically Based Pharmacokinetic Model Describing the Altered Metabolism of Midazolam Due to Inflammation in Mice.
Authors: Varkhede N; Department of Pharmaceutical Chemistry, The University of Kansas, 2095 Constant Ave, Lawrence, Kansas, 66047, USA., Patel N; Drug Disposition, Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, 46285, USA., Chang W; Lilly Biotechnology, Eli Lilly and Company, San Diego, California, 92121, USA., Ruterbories K; Bioanalysis and Biotransformation, Research and Development, AbbVie, North Chicago, Illinois, USA., Forrest ML; Department of Pharmaceutical Chemistry, The University of Kansas, 2095 Constant Ave, Lawrence, Kansas, 66047, USA. lforrest@ku.edu.
Source: Pharmaceutical research [Pharm Res] 2018 Jun 21; Vol. 35 (8), pp. 162. Date of Electronic Publication: 2018 Jun 21.
Publication Type: Journal Article
Journal Info: Publisher: Kluwer Academic/Plenum Publishers Country of Publication: United States NLM ID: 8406521 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-904X (Electronic) Linking ISSN: 07248741 NLM ISO Abbreviation: Pharm Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1573-904X
DOI:10.1007/s11095-018-2447-9